Jed Latkin | Chief Executive Officer, Chief Financial Officer, Chief Operating Officer |
Mike Rosol | Chief Medical Officer |
Erika Eves | Director Finance and Administration |
Mike Okunewitch | Maxim Group |
Vernon Bernardino | H.C. Wainwright |
Michael Liu | Private Investor |
Mike Riccelli | Private Investor |
Thank you. Good afternoon and welcome, everyone, to Navidea's fourth quarter 2019 earnings call. I am Jed Latkin, Chief Executive Officer of Navidea Biopharmaceuticals. This call will cover Navidea's financial and operating results for the fourth quarter of 2019, which ended on December 31, 2019, along with a discussion of goals and milestones for 2020.
Following our prepared remarks, we will open up the conference call to a question-and-answer session.